Vimarsana
Biggest News Aggregation in the World

Page 40 - Roche Group News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Roche Group. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Roche Group Today - Breaking & Trending Today

Update Regarding Pfizer's Statement on COMIRNATY-Related Write-Offs -October 16, 2023 at 03:00 am EDT - Vimarsana News

Update Regarding Pfizer's Statement on COMIRNATY-Related Write-Offs -October 16, 2023 at 03:00 am EDT

MAINZ, Germany, October 16, 2023 -- On October 13, 2023, Pfizer Inc. , a collaboration partner of BioNTech SE , announced a non-cash charge for inventory write-offs and other charges related to...

BioNTech to Present Multiple Program Updates Across - Vimarsana News

BioNTech to Present Multiple Program Updates Across

Program updates include new data for investigational CAR-T and ex-vivo T cell therapies, a novel ADC, a FixVac off-the-shelf mRNA cancer vaccine, and a...

Update Regarding Pfizer's Statement on COMIRNATY-Related Write-Offs -October 16, 2023 at 03:01 am EDT - Vimarsana News

Update Regarding Pfizer's Statement on COMIRNATY-Related Write-Offs -October 16, 2023 at 03:01 am EDT

MAINZ, Germany, October 16, 2023 -- On October 13, 2023, Pfizer Inc. , a collaboration partner of BioNTech SE , announced a non-cash charge for inventory write-offs and other charges related to...

Late-breaking data for Roche's BTK inhibitor fenebrutinib - Vimarsana News

Late-breaking data for Roche's BTK inhibitor fenebrutinib

New data from Phase II FENopta study in relapsing multiple sclerosis (RMS) show fenebrutinib crosses the blood-brain barrier with the potential to act...

New Data for Genentech's Ocrevus Show That After 10 Years of Treatment 77% of People With Relapsing Multiple Sclerosis Were Free From Disability Progression and 92% Continue to Walk Unaided | National Business - Vimarsana News

New Data for Genentech's Ocrevus Show That After 10 Years of Treatment 77% of People With Relapsing Multiple Sclerosis Were Free From Disability Progression and 92% Continue to Walk Unaided | National Business

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Oct 12, 2023--